Back to search
Opioid-induced Constipation (OIC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Opioid-induced Constipation (OIC) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Opioid-induced Constipation (OIC) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of this study is to evaluate the pharmacokinetic (PK) profile of naldemedine and nor-naldemedine after a single oral dose of naldemedine i…
This study looks at how well a medicine called naldemedine works for people with cancer who become constipated while taking opioids. Opioids are medications pre…
The research objective is to characterize the risk of a major adverse cardiovascular event (MACE) among new users of naldemedine versus new users of lubiproston…
More than 70% of patients with cancer in the palliative phase have pain that often requires treatment with opioids (morphine-like agents). Constipation occurs i…
A dose-escalation study to assess the safety, tolerability and clinical activity of TD-1211 in patients with opioid-induced constipation.
A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation